11/9/2010 | PP | GTC Biotherapeutics pockets $18.3 million through placement of stock
|
10/27/2010 | PP | GTC investor proposes the company go private to meet financing needs
|
6/16/2010 | PP | New Issue: GTC Biotherapeutics sells $7 million 4% three-year convertibles at par
|
6/16/2010 | PP | Market Commentary: Pharmacyclics brings offering; Kayne Anderson settles two deals; BNC adds Aquiline as investor
|
11/2/2009 | PP | Market Commentary: Terramin settles equity placement; Cortez Gold aims for C$7 million; GTC to sell shares to LBF
|
11/2/2009 | PP | New Issue: GTC Biotherapeutics secures $3.63 million through placement of shares
|
6/18/2009 | PP | New Issue: GTC Biotherapeutics plans $12.3 million bridge debt, preferreds sale
|
6/18/2009 | PP | Market Commentary: GTC, Roxi tap investors; Advaxis sells notes at 15% discount; Longford plans C$20 million deal
|
11/6/2008 | PP | New Issue: GTC offers more details on $15 million convertible debt sale
|
11/3/2008 | PP | New Issue: GTC plans $15 million convertible debt sale
|
11/3/2008 | PP | Market Commentary: Mount Gibson gets A$66 million lifeline; GTC to sell convertibles; Lihua, Potash One complete deals
|
2/8/2008 | PP | New Issue: GTC Biotherapeutics to sell $6 million of stock, warrants in direct offering
|
2/8/2008 | PP | Market Commentary: GTC raises finance for new drugs; Sierra to boost capacity; Kimber eyes C$5 million sale
|
5/2/2007 | CVHY | GTC Biotherapeutics files $60 million shelf
|
11/2/2006 | BT | GTC predicts current $29.3 million cash position will rise to $50 million by year-end
|
10/5/2006 | BTPP | New Issue: GTC Biotherapeutics releases terms on $25 million financing
|
10/2/2006 | PP | Market Commentary: Accentia stock edges up after $25 million convertibles sale; GTC to close $25 million PIPE
|
10/2/2006 | BTPP | GTC Biotherapeutics to sell $25 million of common stock, convertibles
|
10/2/2006 | BT | Market Commentary: Gilead off, Myogen skyrockets; Accentia up, Biovest off; GTC up after close; Encysive off 3%
|
8/3/2006 | BT | GTC Biotherapeutics reports net loss of $9.1 million for second quarter, revenues down 59%
|
7/19/2006 | BT | Market Commentary: Amgen up slightly ahead of earnings; Isis, NeoPharm, Genta up; Affymetrix off, Illumina up 29%
|
7/19/2006 | PP | Market Commentary: Kosan Biosciences gets $50 million equity line; GTC Biotherapeutics plans $17.53 million stock sale
|
7/19/2006 | BTPP | New Issue: GTC Biotherapeutics plans sale of units for up to $17.54 million
|
7/12/2006 | BT | GTC says European approval of ATryn will help advance entire product portfolio
|
6/15/2006 | BTCV | GTC Biotherapeutics files $35 million shelf
|
6/14/2006 | BT | GTC Biotherapeutics gets $1 million milestone payment from LEO Pharma
|
4/28/2006 | BT | GTC Biotherapeutics first-quarter revenues up 66% to $2.2 million
|
3/6/2006 | BT | GTC Biotherapeutics says revenue falls, loss widens in 2005
|
2/23/2006 | BT | GTC says committee to issue negative opinion on ATryn
|
2/23/2006 | BT | Market Commentary: Kos crashes on results, warning; GTC garroted by E.U. rejection; Nastech higher; Biovail mixed
|
1/9/2006 | BT | GTC Biotherapeutics to receive patent on protein production via milk
|
1/3/2006 | BT | GTC Biotherapeutics draws additional $2.4 million on loan
|
12/9/2005 | PP | Market Commentary: Icop Digital wraps $3.85 million stock deal; soaring gold prices spark surge in PIPE offerings within sector
|
12/8/2005 | PP | Market Commentary: Genius Products settles $32 million stock offering; GTC raises $16.65 million from direct placement
|
12/8/2005 | BTPP | New Issue: GTC Biotherapeutics secures agreements for $16.64 million direct placement of stock
|
11/1/2005 | BT | GTC Biotherapeutics and LEO Pharma to develop and market ATryn
|
10/21/2005 | BT | GTC Biotherapeutics files $50 million shelf
|
8/8/2005 | PP | Market Commentary: Biotechs lead PIPE issuance; Genta raises $17.5 million from direct stock offering
|
8/8/2005 | BTPP | New Issue: GTC Biotherapeutics raises $8 million in private placement of stock
|
1/25/2005 | PP | New Issue: GTC Biotherapeutics raises $10.39 million in a direct placement of shares
|
1/25/2005 | PP | Market Commentary: U.S. private placement volume improves on higher stocks; ArQule raises $31 million in direct placement
|